Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse

Bone

Volumn 42, Issue 4, 2008, Pages 695-701

  Iwaniec, U T ^a   Trevisiol, C H ^b   Maddalozzo, G F ^a   Rosen, C J ^c,d   Turner, R T ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b Oregon State University   (United States)

^c ST JOSEPH HOSPITAL   (United States)

^d JACKSON LABORATORY   (United States)

Author keywords

Bone formation; Fracture healing; Histomorphometry; MicroCT; Osteoporosis

Indexed keywords

ALCOHOL; DEXTRAN; MALTOSE; PARATHYROID HORMONE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BIOSYNTHESIS; BONE DENSITY; BONE GROWTH; BONE MASS; BONE MATRIX; BONE MINERAL; BONE TURNOVER; CALORIC INTAKE; CALORIE; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DIAPHYSIS; IMPLANT; MALE; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; PERIOSTEUM; RAT; SHAM FEEDING; TIBIA;

ALCOHOLISM; ANIMALS; BONE AND BONES; BONE DENSITY; DISEASE MODELS, ANIMAL; INSULIN-LIKE GROWTH FACTOR I; MALE; OSTEOGENESIS; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 40849125378     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.12.221     Document Type: Article

References (45)

1. Forteo approved for osteoporosis treatment. FDA Consum 37 (2003) 4
2. Alkhiary Y.M., Gerstenfeld L.C., Krall E., Westmore M., Sato M., Mitlak B.H., and Einhorn T.A. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 87 (2005) 731-741
3. Komatsubara S., Mori S., Mashiba T., Nonaka K., Seki A., Akiyama T., Miyamoto K., et al. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 36 (2005) 678-687
4. Gallagher J.C., Rosen C.J., Chen P., Misurski D.A., and Marcus R. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis. Bone 39 (2006) 1268-1275
5. Turner R.T. Skeletal response to alcohol. Alcohol Clin Exp Res 24 (2000) 1693-1701
6. Chakkalakal D.A. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 29 (2005) 2077-2090
7. Mathog R.H., Toma V., Clayman L., and Wolf S. Nonunion of the mandible: an analysis of contributing factors. J Oral Maxillofac Surg 58 (2000) 746-752 discussion 752-3
8. Carpintero P., Lopez P., Leon F., Lluch M., Montero M., and Aguilera C. Men with hip fractures have poorer nutritional status and survival than women: a prospective study of 165 patients. Acta Orthop 76 (2005) 331-335
9. Tonnesen H., Pedersen A., Jensen M.R., Moller A., and Madsen J.C. Ankle fractures and alcoholism. The influence of alcoholism on morbidity after malleolar fractures. J Bone Joint Surg Br 73 (1991) 511-513
10. Sibonga J.D., Iwaniec U.T., Shogren K.L., Rosen C.J., and Turner R.T. Effects of parathyroid hormone (1-34) on tibia in an adult rat model for chronic alcohol abuse. Bone 40 (2007) 1013-1020
11. Turner R.T., Evans G.L., Lotinun S., Lapke P.D., Iwaniec U.T., and Morey-Holton E. Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats. J Bone Miner Res 22 (2007) 64-71
12. Trevisiol C.H., Turner R.T., Pfaff J.E., Hunter J.C., Menagh P.J., Hardin K., Ho E., et al. Impaired osteoinduction in a rat model for chronic alcohol abuse. Bone 41 (2007) 175-180
13. Lang C.H., Fan J., Lipton B.P., Potter B.J., and McDonough K.H. Modulation of the insulin-like growth factor system by chronic alcohol feeding. Alcohol Clin Exp Res 22 (1998) 823-829
14. Turner R.T., Wronski T.J., Zhang M., Kidder L.S., Bloomfield S.A., and Sibonga J.D. Effects of ethanol on gene expression in rat bone: transient dose-dependent changes in mRNA levels for matrix proteins, skeletal growth factors, and cytokines are followed by reductions in bone formation. Alcohol Clin Exp Res 22 (1998) 1591-1599
15. Yakar S., Kim H., Zhao H., Toyoshima Y., Pennisi P., Gavrilova O., and Leroith D. The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting. Pediatr Nephrol 20 (2005) 251-254
16. Baron R., Gertner J.M., Lang R., and Vignery A. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Pediatr Res 17 (1983) 204-207
17. Body J.J., Gaich G.A., Scheele W.H., Kulkarni P.M., Miller P.D., Peretz A., Dore R.K., et al. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87 (2002) 4528-4535
18. Dobnig H., and Turner R.T. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138 (1997) 4607-4612
19. Lane N.E., Sanchez S., Modin G.W., Genant H.K., Pierini E., and Arnaud C.D. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102 (1998) 1627-1633
20. Tam C.S., Heersche J.N., Murray T.M., and Parsons J.A. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 110 (1982) 506-512
21. Dobnig H., and Turner R.T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136 (1995) 3632-3638
22. Hamann K.L., and Lane N.E. Parathyroid hormone update. Rheum Dis Clin North Am 32 (2006) 703-719
23. Hodsman A.B., Fraher L.J., Watson P.H., Ostbye T., Stitt L.W., Adachi J.D., Taves D.H., et al. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 82 (1997) 620-628
24. Hodsman A.B., Kisiel M., Adachi J.D., Fraher L.J., and Watson P.H. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis. Bone 27 (2000) 311-318
25. Bikle D.D., Sakata T., Leary C., Elalieh H., Ginzinger D., Rosen C.J., Beamer W., et al. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 17 (2002) 1570-1578
26. Miyakoshi N., Kasukawa Y., Linkhart T.A., Baylink D.J., and Mohan S. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 142 (2001) 4349-4356
27. Wang Y., Nishida S., Boudignon B.M., Burghardt A., Elalieh H.Z., Hamilton M.M., Majumdar S., et al. Igf-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res 22 (2007) 1329-1337
28. Watson P., Lazowski D., Han V., Fraher L., Steer B., and Hodsman A. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 16 (1995) 357-365
29. Schmidt I.U., Dobnig H., and Turner R.T. Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. Endocrinology 136 (1995) 5127-5134
30. Fielder P.J., Mortensen D.L., Mallet P., Carlsson B., Baxter R.C., and Clark R.G. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Endocrinology 137 (1996) 1913-1920
31. Yakar S., Bouxsein M.L., Canalis E., Sun H., Glatt V., Gundberg C., Cohen P., et al. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J Endocrinol 189 (2006) 289-299
32. Lee K.J., Roper J.G., and Wang J.C. Demineralized bone matrix and spinal arthrodesis. Spine J 5 (2005) 217S-223S
33. Toms A.D., Barker R.L., Jones R.S., and Kuiper J.H. Impaction bone-grafting in revision joint replacement surgery. J Bone Joint Surg Am 86-A (2004) 2050-2060
34. Andreassen T.T., and Cacciafesta V. Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects. J Craniofac Surg 15 (2004) 424-427 discussion 428-9
35. Andreassen T.T., Willick G.E., Morley P., and Whitfield J.F. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif Tissue Int 74 (2004) 351-356
36. Nakazawa T., Nakajima A., Shiomi K., Moriya H., Einhorn T.A., and Yamazaki M. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. Bone 37 (2005) 711-719
37. Pettway G.J., Schneider A., Koh A.J., Widjaja E., Morris M.D., Meganck J.A., Goldstein S.A., et al. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone. Bone 36 (2005) 959-970
38. Friedl G., Turner R.T., Evans G.L., and Dobnig H. Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism. J Orthop Res 25 (2007) 1454-1464
39. Sampson H.W., Chaffin C., Lange J., and DeFee II B. Alcohol consumption by young actively growing rats: a histomorphometric study of cancellous bone. Alcohol Clin Exp Res 21 (1997) 352-359
40. Sampson H.W., Perks N., Champney T.H., and DeFee II B. Alcohol consumption inhibits bone growth and development in young actively growing rats. Alcohol Clin Exp Res 20 (1996) 1375-1384
41. Turner R.T., Aloia R.C., Segel L.D., Hannon K.S., and Bell N.H. Chronic alcohol treatment results in disturbed vitamin D metabolism and skeletal abnormalities in rats. Alcohol Clin Exp Res 12 (1988) 159-162
42. Turner R.T., Greene V.S., and Bell N.H. Demonstration that ethanol inhibits bone matrix synthesis and mineralization in the rat. J Bone Miner Res 2 (1987) 61-66
43. Sampson H.W. Effect of alcohol consumption on adult and aged bone: a histomorphometric study of the rat animal model. Alcohol Clin Exp Res 22 (1998) 2029-2034
44. Turner R.T., Kidder L.S., Kennedy A., Evans G.L., and Sibonga J.D. Moderate alcohol consumption suppresses bone turnover in adult female rats. J Bone Miner Res 16 (2001) 589-594
45. Matkovic V., Jelic T., Wardlaw G.M., Ilich J.Z., Goel P.K., Wright J.K., Andon M.B., et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 93 (1994) 799-808